EU to study potential vaccine for Lyme disease: Companies
EU officials have agreed to study an experimental vaccine against Lyme disease, the world's most common tick-borne illness, its developers said Friday.
Aug 14, 2026
0
7
MeSH tree: E05.952
EU officials have agreed to study an experimental vaccine against Lyme disease, the world's most common tick-borne illness, its developers said Friday.
Aug 14, 2026
0
7
A parasitic worm might be the impetus behind a new generation of medicine. In a recent review in published in Clinical & Translational Immunology, Neima Briggs, MD, Ph.D., instructor of medicine (infectious diseases) at Yale ...
Jun 24, 2026
0
4
A study on COVID-19 vaccine effectiveness has finally been published after being blocked from a government health journal.
Jun 24, 2026
0
11
Cholesterol-reducing statin medications to lower the risk of heart attack and stroke; personalized cancer therapies; mRNA technologies that revolutionized vaccine development and are now transforming cancer therapy. These ...
Jun 22, 2026
0
3
A federal report pointing out the benefits of COVID-19 vaccines may never be released, according to multiple people familiar with the decision.
Apr 22, 2026
4
8
A health report on COVID-19 vaccines has been delayed after concerns about how the study was conducted.
Apr 10, 2026
0
12
In pediatric patients, influenza vaccine effectiveness (VE) varied across 2021 to 2024 seasons, but did help prevent influenza-associated hospitalizations and outpatient visits, according to a study published online April ...
Apr 8, 2026
0
4
Genetic modification of viruses has long been used as a strategy to treat and prevent different types of diseases. Specifically, it consists of exploiting certain characteristics of viruses that make them suitable tools for ...
Feb 18, 2026
0
4
Maternal influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations are associated with a lower risk for influenza- and pertussis-related hospitalization or emergency department (ED) visits in infants younger ...
Jan 9, 2026
0
13
Receiving two doses of inactivated influenza vaccine (IIV) in the first year of influenza vaccination is associated with improved protection for children younger than 3 years versus one dose, according to a study published ...
Oct 17, 2025
0
17